INS and systemic lupus erythematosus: The gene of SOCS1 was found to be targeted by insulin and aldesleukin, of which both have been applied to treat autoimmune diseases, including systemic lupus erythematosus [26], type 1 diabetes mellitus [27], and HIV [28].